Altered Monocytic Phenotypes are Associated with Uraemic Pruritus in Patients Receiving Haemodialysis.

CD14++CD16+ monocytes haemodialysis intermediate monocytes itch uraemic pruritus cytokines

Journal

Acta dermato-venereologica
ISSN: 1651-2057
Titre abrégé: Acta Derm Venereol
Pays: Sweden
ID NLM: 0370310

Informations de publication

Date de publication:
22 Jun 2021
Historique:
pubmed: 28 5 2021
medline: 24 6 2021
entrez: 27 5 2021
Statut: epublish

Résumé

Uraemic pruritus is one of the most bothersome symptoms in patients receiving haemodialysis. A total of 175 patients receiving maintenance haemodialysis, with 74 patients experiencing uraemic pruritus, were prospectively recruited to assess the influence of the phenotype of blood monocytes and various cytokines on uraemic pruritus. The phenotype of blood monocytes was determined by flow cytometry as classical (CD14++CD16-) monocytes, non-classical (CD14+CD16++) monocytes, and intermediate (CD14++CD16+) monocytes. Eight cyto-kines, including interleukin (IL)-2, interferon-γ, IL-12p70, IL-4, IL-5, IL-6, tumour necrosis factor-α, and IL-10, were simultaneously detected with a multi-plex bead-based immunoassay. Multivariate linear regression analysis showed that a higher percentage of intermediate monocytes (effect estimate 0.08; 95% confidence interval 0.01-0.16) were independent predictors of a higher visual analogue scale score for pruritus intensity. No differences were noted for all 8 cytokines between patients with and without uraemic pruritus. The results of this study indicate that altered monocytic phenotypes could play a role in uraemic pruritus.

Identifiants

pubmed: 34043016
doi: 10.2340/00015555-3841
pmc: PMC9380278
doi:

Substances chimiques

Cytokines 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

adv00479

Références

J Eur Acad Dermatol Venereol. 2020 Oct;34(10):2368-2372
pubmed: 32170896
J Allergy Clin Immunol. 2016 Oct;138(4):984-1010
pubmed: 27577879
Arthritis Rheum. 2012 Mar;64(3):671-7
pubmed: 22006178
Clin J Am Soc Nephrol. 2010 Aug;5(8):1410-9
pubmed: 20558560
Br J Dermatol. 2011 Sep;165(3):633-9
pubmed: 21668425
J Am Soc Nephrol. 2006 Dec;17(12 Suppl 3):S274-80
pubmed: 17130274
Medicine (Baltimore). 2016 Mar;95(9):e2935
pubmed: 26945400
Immunity. 2010 Sep 24;33(3):375-86
pubmed: 20832340
QJM. 2010 Nov;103(11):837-46
pubmed: 20350963
Am J Kidney Dis. 2015 Nov;66(5):884-930
pubmed: 26498416
J Eur Acad Dermatol Venereol. 2006 Jul;20(6):672-8
pubmed: 16836494
PLoS One. 2013 Aug 06;8(8):e71404
pubmed: 23940749
Nephrol Dial Transplant. 2006 Dec;21(12):3495-505
pubmed: 16968725
Nephron. 1998;78(4):395-402
pubmed: 9578065
Arthritis Res Ther. 2017 Feb 10;19(1):28
pubmed: 28183329
Int J Mol Sci. 2017 Jul 10;18(7):
pubmed: 28698528
PLoS One. 2018 Sep 5;13(9):e0203474
pubmed: 30183756
Immun Ageing. 2018 Nov 08;15:27
pubmed: 30455721
Adv Ren Replace Ther. 1995 Oct;2(4):295-304
pubmed: 8591121
J Am Soc Nephrol. 2016 May;27(5):1479-86
pubmed: 26567245
Nephrol Dial Transplant. 2008 Nov;23(11):3685-9
pubmed: 18515654
Nephrol Dial Transplant. 2011 Oct;26(10):3338-44
pubmed: 21372257
Am J Kidney Dis. 2017 Nov;70(5):638-655
pubmed: 28720208
Acta Derm Venereol. 2021 Feb 11;101(2):adv00390
pubmed: 33521834
Sci Rep. 2018 Jan 17;8(1):919
pubmed: 29343695
Epigenetics. 2016 Apr 2;11(4):259-72
pubmed: 27018948
PLoS One. 2017 Aug 23;12(8):e0183594
pubmed: 28832681
Blood. 2010 Oct 21;116(16):e74-80
pubmed: 20628149
J Cell Mol Med. 2020 Nov;24(21):12504-12512
pubmed: 32949213
Sci Rep. 2016 Dec 19;6:39483
pubmed: 27991581
Blood. 2011 Aug 4;118(5):e16-31
pubmed: 21653326
J Am Soc Nephrol. 2005 Dec;16(12):3742-7
pubmed: 16251241
Acta Derm Venereol. 2013 Mar 27;93(2):214-5
pubmed: 22930335
Nephrol Dial Transplant. 2006 Mar;21(3):749-55
pubmed: 16249205
Kidney Int. 2008 Mar;73(5):622-9
pubmed: 18160960
Acta Derm Venereol. 2001 May;81(2):108-11
pubmed: 11501646
Nat Microbiol. 2016 Dec 19;2:16246
pubmed: 27991883
Blood. 2011 Sep 22;118(12):e50-61
pubmed: 21803849
J Am Acad Dermatol. 2014 Dec;71(6):1151-1159.e1
pubmed: 25270263
Front Immunol. 2018 Jul 30;9:1726
pubmed: 30105020

Auteurs

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH